{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:09:32Z","timestamp":1778314172957,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC81571856"],"award-info":[{"award-number":["NSFC81571856"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.neulet.2018.08.023","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T12:35:19Z","timestamp":1534768519000},"page":"75-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence"],"prefix":"10.1016","volume":"685","author":[{"given":"Ji","family":"Yuanyuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Rui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Jingjing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deji","family":"Cuola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi","family":"Yuhui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Shuguang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2018.08.023_bib0005","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nn1583","article-title":"Genetic Influences on Impulsivity, Risk Taking, Stress Responsivity and Vulnerability to Drug Abuse and Addiction","volume":"8","author":"Kreek","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neulet.2018.08.023_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrg2536","article-title":"New insights into the genetics of addiction","volume":"10","author":"Li","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ajad.12316","article-title":"Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms","volume":"25","author":"Jones","year":"2016","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.neulet.2018.08.023_bib0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ajmg.b.30510","article-title":"Human kappa opioid receptor gene (Oprk1) polymorphism is associated with opiate addiction","volume":"144b","author":"Gerra","year":"2007","journal-title":"Am. J. Med. Genet. Part B-Neuropsychiatric Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainresbull.2011.02.010","article-title":"Association between heroin dependence and prodynorphin gene polymorphisms","volume":"85","author":"Wei","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2018.08.023_bib0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","volume":"11","author":"Xuei","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.023_bib0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.psychres.2013.11.001","article-title":"Association between gene variants and response to buprenorphine maintenance treatment","volume":"215","author":"Gerra","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2018.08.023_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/YPG.0000000000000008","article-title":"The kappa-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial","volume":"23","author":"Nielsen","year":"2013","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0045","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"Kappa-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2018.08.023_bib0050","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","article-title":"Genetic susceptibility to heroin addiction: a candidate gene association study","volume":"7","author":"Levran","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neulet.2018.08.023_bib0055","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","volume":"11","author":"Xuei","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.023_bib0060","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.mp.4002035","article-title":"The Oprd1 and Oprk1 loci in alcohol or drug dependence: Oprd1 variation modulates substance dependence risk","volume":"13","author":"Zhang","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.023_bib0065","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/hmg\/ddn068","article-title":"A regulatory variation in Oprk1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence","volume":"17","author":"Edenberg","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1369-1600.2010.00248.x","article-title":"Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity","volume":"16","author":"Rouault","year":"2011","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neulet.2018.08.023_bib0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2011.02.042","article-title":"Prodynorphin promoter Snp associated with alcohol dependence forms noncanonical Ap-1 binding site that may influence gene expression in human brain","volume":"1385","author":"Taqi","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2018.08.023_bib0080","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00008571-200412000-00002","article-title":"Redefinition of the human kappa opioid receptor gene (Oprk1) structure and association of haplotypes with opiate addiction","volume":"14","author":"Yuferov","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.neulet.2018.08.023_bib0085","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","article-title":"The structure of haplotype blocks in the human genome","volume":"296","author":"Gabriel","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neulet.2018.08.023_bib0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humimm.2014.12.005","article-title":"Association between DRD2\/ANKK1 TaqIA polymorphism and common illicit drug dependence: evidence from a meta-analysis","volume":"76","author":"Deng","year":"2015","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.neulet.2018.08.023_bib0095","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ajmg.10362","article-title":"Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse","volume":"114","author":"Chen","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ajmg.b.30238","article-title":"Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence","volume":"139b","author":"Dahl","year":"2005","journal-title":"Am. J. Med. Genet. Part B-Neuropsychiatric Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0105","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2006.02.038","article-title":"Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence","volume":"400","author":"Nomura","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neulet.2018.08.023_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00041444-200512000-00013","article-title":"A functional prodynorphin promoter polymorphism and opioid dependence","volume":"15","author":"Ray","year":"2005","journal-title":"Psychiatr. Genet."},{"key":"10.1016\/j.neulet.2018.08.023_bib0115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00213-008-1122-y","article-title":"Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system","volume":"200","author":"Redila","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neulet.2018.08.023_bib0120","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1471-4159.2000.740472.x","article-title":"An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression","volume":"74","author":"Zimprich","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2018.08.023_bib0125","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/molbev\/msp276","article-title":"Multiple functional variants in Cis modulate Pdyn expression","volume":"27","author":"Babbitt","year":"2010","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.neulet.2018.08.023_bib0130","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/NDT.S159954","article-title":"Gender-specific association of functional prodynorphin 68 Bp repeats with cannabis exposure in an african american cohort","volume":"14","author":"Yuferov","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neulet.2018.08.023_bib0135","first-page":"147","article-title":"Pathway-and cell-specific kappa-opioid receptor modulation of excitation-inhibition balance differentially gates D1 and D2 accumbens","volume":"93","author":"Tejeda","year":"2017","journal-title":"Neuron Activity Neuron"},{"key":"10.1016\/j.neulet.2018.08.023_bib0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2007.05.007","article-title":"Reinstatement of cocaine place-conditioning prevented by the peptide kappa-opioid receptor antagonist arodyn","volume":"569","author":"Carey","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.023_bib0145","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","article-title":"Association of the kappa-opioid system with alcohol dependence","volume":"11","author":"Xuei","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.023_bib0150","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.tins.2012.05.005","article-title":"\u03ba-opioid receptor\/dynorphin system: genetic and pharmacotherapeutic implications for addiction","volume":"35","author":"Butelman","year":"2012","journal-title":"Trends Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018305688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018305688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:22:24Z","timestamp":1759609344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394018305688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"alternative-id":["S0304394018305688"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2018.08.023","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2018.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}